SPONSORED CONTENT
Cloudmed routinely analyzes aggregate data to identify 340B program trends and patterns that can provide useful client insights regarding referral prescriptions. Our 340B team observed two calendar years of data across more than 230 covered entity sites to understand which drugs, therapeutic classes, and medical specialties account for the largest savings realized through referral prescriptions within the contract pharmacy domain.
Top Level Findings
Hepatology And Hematology/Oncology Medications Account For Most Savings
In both CY 2020 and CY 2021, hepatology and hematology/oncology medications consistently account for more than 50% of the top ten medications realized within referral management.
Hepatology medications HARVONI, EPCLUSA, and SYPRINE – drugs used to treat hepatitis and liver disorders – were consistently ranked across both 2020 and 2021. The capture of neurology medications indicated for treating multiple sclerosis and
…